We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.5M
Cap. Flow
-$16.8M
Cap. Flow %
-15.73%
Top 10 Hldgs %
2.69%
Holding
2,904
New
705
Increased
558
Reduced
830
Closed
739

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$423K
2
GIS icon
General Mills
GIS
+$314K
3
MO icon
Altria Group
MO
+$234K
4
PX
Praxair Inc
PX
+$231K
5
ATR icon
AptarGroup
ATR
+$231K

Sector Composition

Rank Sector Weight
1 Industrials 15.12%
2 Healthcare 14.17%
3 Financials 13.11%
4 Consumer Discretionary 12.41%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYNE
2626
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-546
Closed -$11K
SPPI
2627
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-6,455
Closed -$42K
IMBI
2628
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-1,782
Closed -$23K
SIRE
2629
DELISTED
Sisecam Resources LP
SIRE
-982
Closed -$28K
AUD
2630
DELISTED
Audacy, Inc.
AUD
-229
Closed -$3K
VYNT
2631
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-74
Closed -$45K
BBBY
2632
DELISTED
Bed Bath & Beyond Inc
BBBY
-800
Closed -$32K
FRC
2633
DELISTED
First Republic Bank
FRC
-400
Closed -$38K
OIG
2634
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-7
Closed -$1K
PLXP
2635
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-528
Closed -$5K
AGRX
2636
DELISTED
Agile Therapeutics
AGRX
-3
Closed -$22K
AUY
2637
DELISTED
Yamana Gold, Inc.
AUY
-8,471
Closed -$23K
ALR
2638
DELISTED
AlerisLife Inc
ALR
-9
Closed
HZN
2639
DELISTED
Horizon Global Corporation
HZN
-123
Closed -$2K
HTGM
2640
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
-1
Closed -$1K
AGTC
2641
DELISTED
Applied Genetic Technologies Corporation
AGTC
-6,661
Closed -$46K
ZEN
2642
DELISTED
ZENDESK INC
ZEN
-1,400
Closed -$39K
FNHC
2643
DELISTED
FedNat Holding Company Common Stock
FNHC
-6,717
Closed -$117K
CYBE
2644
DELISTED
Cyberoptics Corp
CYBE
-1,802
Closed -$47K
MN
2645
DELISTED
MANNING & NAPIER, INC.
MN
-3,729
Closed -$21K
GBT
2646
DELISTED
Global Blood Therapeutics, Inc.
GBT
-394
Closed -$15K
DRE
2647
DELISTED
Duke Realty Corp.
DRE
-1,600
Closed -$42K
ABTX
2648
DELISTED
Allegiance Bancshares
ABTX
-877
Closed -$33K
GCP
2649
DELISTED
GCP Applied Technologies Inc.
GCP
-1,879
Closed -$61K
AXU
2650
DELISTED
Alexco Resource Corp
AXU
-54,297
Closed -$83K

Similar funds

Acrospire Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Acrospire Investment Management held 2,904 positions worth $107M, down 12% from $121M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management withdrew a net $16.8M in Q2 2017, closing 739 positions and reducing 830 holdings. Its most notable exit was Bunge Global, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Acrospire Investment Management opened a new position in Procter & Gamble worth $418K.

  • Acrospire Investment Management's largest Q2 2017 buy was Procter & Gamble: 4,800 shares worth $418K.
  • Acrospire Investment Management added most to General Mills in Q2 2017, an estimated $314K increase.
  • Acrospire Investment Management's biggest Q2 2017 reduction was Navios Maritime Acquisition Corporation, cutting an estimated $1.35M.
  • Acrospire Investment Management fully exited Bunge Global in Q2 2017, selling an estimated $285K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $107M portfolio in Q2 2017.
  • Acrospire Investment Management opened 705 new positions and closed 739 in Q2 2017.
  • Acrospire Investment Management's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.